Clinical administration of platelet-rich plasma and growth factors to the musculoskeletal system

Platelet-rich plasma (PRP) and growth factors have been increasing in popularity for the orthopedic treatment of degenerative and traumatic diseases. The treatment concept is based on the substitution of growth-inducing substances in tissues with low or absent regeneration capacity (cartilage, tendo...

Full description

Saved in:
Bibliographic Details
Published inDer Orthopäde Vol. 48; no. 1; pp. 105 - 116
Main Authors Leitner, L, Gruber, G, Lohberger, B, Kaltenegger, H, Leithner, A, Sadoghi, P
Format Journal Article
LanguageGerman
Published Germany 01.01.2019
Subjects
Fibroblast growth factor
Bone morphogenetic proteins
Fractures
Vascular endothelial growth factor
Tissue Engineering
Online AccessGet full text

Cover

More Information
Summary:Platelet-rich plasma (PRP) and growth factors have been increasing in popularity for the orthopedic treatment of degenerative and traumatic diseases. The treatment concept is based on the substitution of growth-inducing substances in tissues with low or absent regeneration capacity (cartilage, tendons) as well as for the induction or further acceleration of growth and regeneration (bone, muscle). This review article provides an overview on the clinical feasibility of usage and a summary of the current study situation.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1433-0431
DOI:10.1007/s00132-018-3643-3